Bellevue Life Sciences Acquisition Corp. (BLAC)
NASDAQ: BLAC · IEX Real-Time Price · USD
10.69
0.00 (0.00%)
Apr 25, 2024, 3:58 PM EDT - Market closed

Company Description

Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities.

The company intends to acquire companies in the healthcare industry. Bellevue Life Sciences Acquisition Corp. was founded in 2020 and is based in Bellevue, Washington.

Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.

Bellevue Life Sciences Acquisition Corp.
Bellevue Life Sciences Acquisition logo
Country United States
Founded 2020
IPO Date Feb 10, 2023
Industry Shell Companies
Sector Financials
CEO Kuk Hyoun Hwang

Contact Details

Address:
10900 Ne 4th Street, Suite 2300
Bellevue, Washington 98004
United States
Phone 425-635-7700

Stock Details

Ticker Symbol BLAC
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $10.00
CIK Code 0001840425
ISIN Number US0791741087
Employer ID 84-5052822
SIC Code 3841

Key Executives

Name Position
Kuk Hyoun Hwang Chief Executive Officer and Director
David Jin Yoo Chief Financial Officer

Latest SEC Filings

Date Type Title
Apr 22, 2024 8-K Current Report
Apr 17, 2024 10-K Annual Report
Apr 16, 2024 PRE 14A Other preliminary proxy statements
Apr 11, 2024 8-K Current Report
Apr 2, 2024 NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Mar 13, 2024 8-K Current Report
Feb 21, 2024 8-K Current Report
Feb 13, 2024 8-K Current Report
Feb 8, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Feb 5, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals